Contractor Doosan Babcock has been awarded a contract to create a brand new Active Pharmaceutical Ingredients (API) facility at the Glaxo Smith Kline site in Montrose.
The contract, worth around £25 million, will see the UK engineering firm work with GSK to design, build and install the API facility which, on completion, will produce active ingredients for three of GSK’s new medicines for the management of respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease . GSK’s existing Montrose operations currently cater for over 20 million patients every day.
Project Starting Date12.01.2016
Project EndIn Progress
GSK new building with process vessels and required to control the purge system for their both their atex rating and safety systems within the building.
Hamall supplied flowmeters to control their nitrogen supply to all vessels with indication and transmission for control that complies with the safety systems on site.
Scope of Supply
Variable Area flow Meter
- Financial Responsibility to Our Clients
- Superior Quality and Craftsmanship
- Quality and Value to the Projects We Deliver
- Highest Standards in Cost Control